Anxiety in diabetic patients. Other stimulant dependence with stimulant-induced anxiety disorder
Conditions
Interventions
Intervention 1: This study is cross-sectional in three groups, where each group is conducted in two stages as an intervention and one stage as a control group. The intervention in the first group is a
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having a medical record with confirmed diabetes Diagnosing the patient's diabetes in the last three months Having moderate to severe anxiety The patient is in the age range of 18 to 65 years Having the physical and mental ability to answer questions Aware of time, place and person
Exclusion criteria
Exclusion criteria: Allergy to scented plants The patient suffers from mental and nervous problems Having a history of allergies and respiratory disease Impaired alertness, olfactory disturbances, dissatisfaction after inhalation Hemodynamic instability during intervention (such as symptoms of anaphylactic shock, severe fluctuations in blood pressure, blood sugar, and any severe disorder and the need for immediate intervention in vital signs) Decreased level of consciousness during intervention Participant's unwillingness to continue participating in the study and death Having chronic diabetic complications such as kidney failure, heart failure, visual impairment and neuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overt and hidden anxiety scores according to Spielberger's standard questionnaire. Timepoint: After filling in the demographic questionnaire and before the aromatherapy as a pre-test and at the end of 20 minutes of aromatherapy as a post-test, anxiety is measured by the Spielberger questionnaire. Method of measurement: Spielberger questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Hossein Taklif
Bandare-abbas University of Medical Sciences
Outcome results
None listed